Omidopa C Levodopa & Carbidopa Tablet

  • Product Name : Omidopa C Levodopa & Carbidopa Tablet
  • Category : Tablet
  • Manufacturer Name : Omicron Pharma
  • Trade Name : Omidopa C Levodopa & Carbidopa Tablet
  • Available Dosage : 10*10 Tablets
  • Packing : Strip
  • Pack Insert/Leaflet : 1 Pack/100 Tablets
  • Ingredients : Levodopa Carbidopa
  • Formulation : Tablet
  • Therapeutic use : to treat Parkinson's disease, sometimes called shaking palsy or paralysis agitans
  • Production Capacity : 100000

Description:-

Introduction to Omidopa C Levodopa & Carbidopa Tablets

Omidopa C combines two active ingredients: levodopa and carbidopa. This combination works synergistically to address the motor symptoms of Parkinson's disease and other similar disorders. Levodopa is a precursor to dopamine, which helps improve movement and coordination, while carbidopa prevents the premature conversion of levodopa to dopamine before it reaches the brain.


Uses of Omidopa C Levodopa & Carbidopa Tablets

Parkinson's Disease Treatment: Effective in reducing the motor symptoms of Parkinson's disease, including tremors, stiffness, and bradykinesia.

Parkinsonism Management: Useful in treating parkinsonism due to other causes, including drug-induced parkinsonism.

Symptom Control: Helps in controlling symptoms and improving the quality of life for individuals with motor disorders.


Benefits of Omidopa C Levodopa & Carbidopa Tablets

Enhanced Dopamine Levels: Increases dopamine levels in the brain, improving motor function and reducing symptoms of Parkinson's disease.

Reduced Motor Symptoms: Helps alleviate key symptoms such as tremors, rigidity, and bradykinesia.

Combination Effectiveness: The combination of levodopa and carbidopa provides more effective symptom control than levodopa alone.

Improved Quality of Life: Helps enhance daily functioning and overall quality of life for individuals with Parkinson's disease.


Mechanism of Action of Omidopa C Levodopa & Carbidopa Tablets

Levodopa Conversion: Levodopa is converted into dopamine in the brain, which helps improve motor function and control symptoms of Parkinson's disease.

Carbidopa Protection: Carbidopa inhibits the enzyme aromatic L-amino acid decarboxylase (AAAD) in the peripheral tissues, preventing the premature conversion of levodopa to dopamine outside the brain. This increases the amount of levodopa available to cross the blood-brain barrier.

Synergistic Effect: The combination of levodopa and carbidopa provides more effective and sustained relief of Parkinson's disease symptoms by maximizing the availability of dopamine in the brain.